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Review question
We will employ systematic review of the literature, along with a quantitative meta-analysis with three goals:
1) synthesize the evidence from published studies evaluating interventions to increase CRC screening
uptake among African-American men; 2) assess the methodological quality of this evidence; and 3)
quantitatively assess the evidence from these published studies through meta-analysis in order to determine
the most effective screening uptake interventions for African-American men. 
 
Searches
The following databases were searched from 11/2/18 to 12/14/18: MEDLINE (Ovid), CINAHL (EBSCO) ,
Embase (Ovid), Cochrane Central Register of Controlled Trials (CENTRAL) (Wiley). The concepts were
colorectal cancer, screening, African American, and men. Both thesaurus terms and keywords were
searched for each concept. After 1998
 
Types of study to be included
Studies which are empirical and use primary data analysis and collection are included in the meta-analysis
and systematic review. Furthermore, these studies must highlight the intervention performed and an analysis
of the intervention's effectiveness. Literature reviews, meta-analysis, or studies which use data from a
secondary source will not be included in the meta-analysis and systematic review.
 
Condition or domain being studied
Colorectal cancer (CRC) is the third most commonly diagnosed cancer in the U.S. and the second leading
cause of cancer related deaths. African-American men are disproportionately impacted by CRC,
experiencing the lowest five-year survival rate of any other demographic group and are 27% more likely of
having CRC as compared to white men. It is well documented that CRC screening is a highly effective
preventive measure against the disease, yet screening uptake remains low among African-American men.
 
Participants/population
The population of interest for this meta-analysis and systematic review is African-American men in the U.S.
The study population is not limited by educational attainment level, socioeconomic status, or other criteria.
Interventions which only target women, race/ethnicity not including African Americans, or are conducted in
countries outside of the United States, were excluded.
 
Intervention(s), exposure(s)
Interventions aimed at increasing CRC screening vary greatly, and many of which will be discovered through
the systematic review process. Potential interventions include: providing patients with printed educational
materials, providing patient care navigation services, conducting phone calls to encourage and remind
patients about screening, accessing common community events/happenings (church, fairs, barbershops,
etc.) and promoting CRC screening, mailing appointment reminders and or educational materials, promoting
CRC screening education via primary care physicians, or hosting group educational meetings.
 
Comparator(s)/control
Examined studies may compare two interventions against one another or compare an intervention against no
intervention. Control or comparison groups, where used, are samples taken from the same or similar
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Context
Exclusion criteria includes: (1) study focus (about CRCscreening uptake/completion), (2) a primary, empirical
study, (3) published in 1998 or beyond; (4) conducted in the U.S., (5) language of the article/study (English),
(6) study sample includes African-American men; (7) whether an intervention/trial was described, and (8)
whether an intervention/trial was evaluated. 
 
Main outcome(s)
The primary outcomes of this meta-analysis and systematic review is to determine the effectiveness of CRC
uptake interventions. Studies will be defined effective if they provide statistically significant evidence that an
intervention has increased the number of African-American men who have received CRC screening (CRCS)
when compared to average CRCS uptake among the same population. Studies which lack evidence of
statistically significant improved CRCS rates will also be useful in determining the best method for increasing
CRCS among African-American men. Consequently, studies that will be included in this meta-analysis and
systematic review must provide details of the intervention used and whether it was evaluated.
Timing and effect measures
 
Additional outcome(s)
None
Timing and effect measures
 
Data extraction (selection and coding)
Studies are screened by using the Rayyan software, with a total of 966 articles were identified for initial
screening. Exclusion criteria includes: study focus (about colorectal cancer screening), study design, date
published (>1997), study location (performed in the U.S.), language of the article/study (English),
race/ethnicity of study population (African American), whether an intervention was performed, and whether
an evaluation of the intervention was performed. After initial screening is complete, a full text selection will be
completed.
 
Risk of bias (quality) assessment
To establish the reliability of the methodological quality scoring (MQS) processes and data abstraction, 25%
of the studies will be randomly selected and assigned to two reviewers. The risk of bias tool will stem from a
modification of previous MQS tool published by the first author. Percent agreement will be calculated;
reviewers will discuss their disagreements, and consensus will be achieved prior to assigning the final MQS.
 
Strategy for data synthesis
After the full text screening data will be extracted according to study characteristics, sample population
characteristics, findings, and limitations. Where applicable, effect sizes will be calculated for each included
study. Effect sizes will be grouped by intervention type in an effort to determine the impact of different types
of interventions on the outcome under observation. A synthesized effect size will then be calculated for each
intervention group. The synthesized effect sizes will allow for comparison between intervention type.
 
Analysis of subgroups or subsets
Based on current trends, CRC incidence rates among those ages 20-34 are predicted to increase 90%-124%
by 2030, and 28%-46% among Americans ages 35-49. Further, the American Cancer Society updated their
guidelines for recommended CRC screening from age 50 to age 45 on May 30, 2018, in direct response to
the increase in incidence of early age onset CRC. Accordingly, the research team will see which
interventions included African-American men younger than age 50.
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